NOVARTIS AG-SPONSORED ADR (NVS) Stock Earnings Estimates
NYSE:NVS • US66987V1098
163.1 USD
+1.92 (+1.19%)
At close: Feb 13, 2026
163.1 USD
0 (0%)
After Hours: 2/13/2026, 4:36:44 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 46.66B 7.57% | 51.722B 10.85% | 56.33B 8.91% | 58.096B 3.14% | 60.501B 4.14% | 63.728B 5.33% | 66.852B 4.90% | 70.264B 5.10% | 69.762B -0.71% | 66.873B -4.14% | 65.94B -1.40% | |
| EBITDA YoY % growth | 20.919B 20.31% | 20.919B | 24.017B 14.81% | 23.863B -0.64% | 25.139B 5.35% | 30.91B 22.96% | 30.07B -2.72% | 30.359B 0.96% | 28.979B -4.55% | 27.089B -6.52% | 25.977B -4.10% | |
| EBIT YoY % growth | 12.642B 23.87% | 16.32B 29.09% | 18.692B 14.53% | 21.458B 14.80% | 22.808B 6.29% | 25.925B 13.67% | 26.276B 1.35% | 27.887B 6.13% | 28.536B 2.33% | 26.905B -5.72% | 24.334B -9.56% | |
| Operating Margin | 27.09% | 31.55% | 33.18% | 36.94% | 37.70% | 40.68% | 39.30% | 39.69% | 40.90% | 40.23% | 36.90% | |
| EPS YoY % growth | 6.94 12.75% | 7.85 13.19% | 9.03 14.98% | 9.38 3.87% | 10.05 7.22% | 11.23 11.68% | 11.64 3.63% | 12.24 5.22% | 12.25 0.04% | 11.53 -5.86% | 9.91 -14.10% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 2.20 -3.99% | 2.32 -4.45% | 2.27 0.50% | 2.05 0.24% |
| Revenue Q2Q % growth | 13.821B 4.44% | 14.477B 3.01% | 14.452B 3.90% | 14.414B 8.08% |
| EBITDA Q2Q % growth | 4.868B -18.05% | 5.806B -23.25% | 5.692B -31.91% | 5.522B -41.82% |
| EBIT Q2Q % growth | 5.186B 8.36% | 5.565B 7.95% | 5.569B 21.46% | 5.091B 22.20% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 2.04 2.53% | 2.04 | 0.00 | -0.17% |
| Q3 2025 Q2Q % growth | 2.26 9.22% | 2.31 | -0.05 | -2.10% |
| Q2 2025 Q2Q % growth | 2.43 22.84% | 2.42 | 0.01 | 0.61% |
| Q1 2025 Q2Q % growth | 2.29 26.67% | 2.15 | 0.14 | 6.59% |
| Q4 2024 Q2Q % growth | 1.99 29.41% | 1.88 | 0.11 | 6.06% |
| Q3 2024 Q2Q % growth | 2.07 12.57% | 2.00 | 0.08 | 3.78% |
| Q2 2024 Q2Q % growth | 1.98 7.65% | 1.92 | 0.06 | 3.24% |
| Q1 2024 Q2Q % growth | 1.81 5.26% | 1.72 | 0.09 | 5.40% |
| Q4 2023 Q2Q % growth | 1.54 0.66% | 1.66 | -0.12 | -7.44% |
| Q3 2023 Q2Q % growth | 1.84 15.82% | 1.77 | 0.07 | 3.88% |
| Q2 2023 Q2Q % growth | 1.84 17.31% | 1.74 | 0.10 | 5.73% |
| Q1 2023 Q2Q % growth | 1.72 17.12% | 1.57 | 0.15 | 9.32% |
| Q4 2022 Q2Q % growth | 1.53 8.57% | 1.44 | 0.09 | 6.28% |
| Q3 2022 Q2Q % growth | 1.59 -7.60% | 1.59 | 0.00 | -0.02% |
| Q2 2022 Q2Q % growth | 1.57 -6.02% | 1.54 | 0.03 | 2.08% |
| Q1 2022 Q2Q % growth | 1.47 -3.95% | 1.48 | -0.01 | -0.62% |
| Q4 2021 Q2Q % growth | 1.41 4.48% | 1.45 | -0.05 | -3.12% |
| Q3 2021 Q2Q % growth | 1.72 12.50% | 1.69 | 0.03 | 1.93% |
| Q2 2021 Q2Q % growth | 1.67 22.06% | 1.58 | 0.09 | 5.67% |
| Q1 2021 Q2Q % growth | 1.53 -2.56% | 1.60 | -0.07 | -4.32% |
| Q4 2020 Q2Q % growth | 1.35 | 1.41 | -0.06 | -4.21% |
| Q3 2020 Q2Q % growth | 1.53 | 1.49 | 0.04 | 2.60% |
| Q2 2020 Q2Q % growth | 1.37 | 1.36 | 0.01 | 0.78% |
| Q1 2020 Q2Q % growth | 1.57 | 1.43 | 0.14 | 9.89% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 13.336B 1.39% | 14.022B | -686M | -4.89% |
| Q3 2025 Q2Q % growth | 13.909B 8.47% | 14.312B | -403M | -2.82% |
| Q2 2025 Q2Q % growth | 14.054B 12.32% | 14.465B | -411M | -2.84% |
| Q1 2025 Q2Q % growth | 13.233B 11.87% | 13.384B | -151M | -1.13% |
| Q4 2024 Q2Q % growth | 13.153B 15.14% | 13.051B | 102M | 0.78% |
| Q3 2024 Q2Q % growth | 12.823B 8.84% | 12.994B | -171M | -1.32% |
| Q2 2024 Q2Q % growth | 12.512B -8.15% | 12.61B | -98M | -0.78% |
| Q1 2024 Q2Q % growth | 11.829B 7.08% | 11.709B | 120M | 1.02% |
| Q4 2023 Q2Q % growth | 11.423B 4.99% | 11.996B | -573M | -4.78% |
| Q3 2023 Q2Q % growth | 11.782B 9.26% | 12.001B | -219M | -1.82% |
| Q2 2023 Q2Q % growth | 13.622B -37.26% | 13.518B | 104M | 0.77% |
| Q1 2023 Q2Q % growth | 11.047B -13.79% | 12.877B | -1.83B | -14.21% |
| Q4 2022 Q2Q % growth | 10.88B 135.55% | 13.285B | -2.405B | -18.10% |
| Q3 2022 Q2Q % growth | 10.783B -19.33% | 13.106B | -2.323B | -17.72% |
| Q2 2022 Q2Q % growth | 21.712B 63.32% | 13.109B | 8.603B | 65.63% |
| Q1 2022 Q2Q % growth | 12.814B 0.95% | 12.942B | -128M | -0.99% |
| Q4 2021 Q2Q % growth | 4.619B -64.55% | 13.616B | -8.997B | -66.08% |
| Q3 2021 Q2Q % growth | 13.367B 6.61% | 13.285B | 82M | 0.62% |
| Q2 2021 Q2Q % growth | 13.294B 14.39% | 12.773B | 521M | 4.08% |
| Q1 2021 Q2Q % growth | 12.694B -0.11% | 12.771B | -77M | -0.60% |
| Q4 2020 Q2Q % growth | 13.03B | 13.147B | -117M | -0.89% |
| Q3 2020 Q2Q % growth | 12.538B | 12.818B | -280M | -2.18% |
| Q2 2020 Q2Q % growth | 11.622B | 12.13B | -508M | -4.19% |
| Q1 2020 Q2Q % growth | 12.708B | 12.249B | 459M | 3.75% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3.08% | -8.65% | -0.62% | -1.74% |
| Revenue | -1.89% | 0.91% | 0% | -0.02% |